Clinical trials
Acquired Immunodeficiency Syndrome trials in South Africa
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
166 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 5 |
| 2005 | 6 |
| 2007 | 5 |
| 2008 | 6 |
| 2009 | 10 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 6 |
| 2014 | 6 |
| 2015 | 10 |
| 2016 | 11 |
| 2017 | 7 |
| 2018 | 6 |
| 2019 | 10 |
| 2020 | 6 |
| 2021 | 12 |
| 2022 | 14 |
| 2023 | 8 |
| 2024 | 7 |
| 2025 | 5 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 123 |
| Recruiting | 16 |
| Active, not recruiting | 12 |
| Unknown status | 8 |
| Terminated | 4 |
| Withdrawn | 2 |
| No longer available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ViiV Healthcare | 14 |
| University of California, Los Angeles | 7 |
| University of Cape Town | 7 |
| Johns Hopkins University | 6 |
| Merck Sharp & Dohme LLC | 6 |
| Tibotec Pharmaceuticals, Ireland | 6 |
| Boston University | 5 |
| Massachusetts General Hospital | 5 |
| Gilead Sciences | 4 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 166 |
| HIV Infections | 44 |
| Tuberculosis | 12 |
| Infections | 10 |
| Substance-Related Disorders | 7 |
| Sexually Transmitted Diseases | 6 |
| Uterine Cervical Neoplasms | 5 |
| Alcoholism | 3 |
| COVID-19 | 3 |
| Immune System Diseases | 3 |
Trials
Showing 76 to 100 of 166. Each trial links to its page on Pharma Observatory.
66 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.